Pendle is trading at $2.15, up 2.62% over 24 hours, and sits just below the session high of $2.16 after ranging from $2.06 to $2.16. This points to a positive short-term move, but a single day’s gain does not outweigh the weaker returns over the preceding one and two weeks.

The hourly moving averages provide near-term support for the rebound: price is above the 8-, 13-, 21-, and 55-hour averages at $2.12–$2.14. However, it remains below the 144-hour average of $2.28, by 5.75%, so the shorter-term improvement has not yet reversed that longer hourly trend signal.

Momentum readings are mixed. The 1-hour RSI of 68 reflects strong recent hourly momentum but is elevated, leaving less room for further gains before momentum becomes stretched; the 7-day RSI of 44 is below the midpoint and is consistent with subdued weekly momentum.

The return data reinforce that conflict. PENDLE has gained 9.71% over 30 days, yet is down 8.76% over seven days and 16.46% over 14 days, indicating that the longer monthly performance has not prevented a recent pullback.

The 24-hour volume is 44.8 million, with volume equal to 11.98% of market capitalization. This gives a measure of the day’s trading activity, but without a comparison period it does not establish whether participation is increasing or unusually high.

PENDLE is also about 71.3% below its $7.50 all-time high from April 11, 2024. That historical gap provides context for the price level, but by itself does not show whether the token is likely to recover or continue falling.

Overall, the evidence supports a Hold rating. The daily advance, position above four short hourly averages, and positive 30-day return are constructive, but they are counterbalanced by the negative seven- and 14-day returns, the below-midpoint weekly RSI, and price remaining below the 144-hour average.

The primary reason to hold rather than buy is that the rebound has not yet offset the recent decline or cleared the longer hourly average. The primary reason not to sell is the positive daily move, short-average alignment, and positive 30-day performance, which leave the evidence mixed rather than decisively bearish.